27.11.2012 Views

Download the 2009 annual report in PDF format - ANF

Download the 2009 annual report in PDF format - ANF

Download the 2009 annual report in PDF format - ANF

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The extraord<strong>in</strong>ary resolutions propose:<br />

• to change <strong>the</strong> Company’s name to “<strong>ANF</strong> Immobilier”, and<br />

consequent amendment of <strong>the</strong> Articles of Association (8th<br />

resolution);<br />

• to renew <strong>the</strong> authorisation given to <strong>the</strong> Executive Board to<br />

reduce <strong>the</strong> share capital by cancell<strong>in</strong>g shares bought <strong>in</strong> <strong>the</strong> share<br />

buyback programmes, <strong>in</strong> one or more transactions, up to a limit<br />

of 10% per 24-month period (9th resolution);<br />

• to renew <strong>the</strong> Executive Board’s authorisations, delegations of<br />

authority and delegation of powers, notably <strong>in</strong> relation to <strong>the</strong> issue<br />

of shares and/or securities giv<strong>in</strong>g rights to shares:<br />

• <strong>the</strong> authorisation to <strong>in</strong>crease <strong>the</strong> share capital by capitalis<strong>in</strong>g<br />

reserves, earn<strong>in</strong>gs or share, merger or contribution premiums,<br />

tak<strong>in</strong>g <strong>the</strong> maximum nom<strong>in</strong>al amount of <strong>the</strong> <strong>in</strong>creases <strong>in</strong><br />

capital to €25 million; <strong>in</strong> particular, this authorisation will enable<br />

<strong>the</strong> Executive Board to grant bonus allocations of shares to<br />

shareholders (10th resolution),<br />

• <strong>the</strong> authorisation to <strong>in</strong>crease <strong>the</strong> share capital by issu<strong>in</strong>g, with<br />

pre-emptive subscription rights, shares and securities giv<strong>in</strong>g<br />

immediate or future rights to shares <strong>in</strong> <strong>the</strong> Company (11th<br />

resolution).<br />

The maximum value of shares that may be issued directly or on<br />

presentation of debt <strong>in</strong>struments is €25 million,<br />

The maximum value of securities that may be issued <strong>in</strong> relation<br />

to debt <strong>in</strong>struments is €100 million;<br />

• <strong>the</strong> authorisation to <strong>in</strong>crease <strong>the</strong> share capital through <strong>the</strong><br />

issue of shares and/or securities conferr<strong>in</strong>g immediate and/<br />

or future rights to Company shares, without pre-emptive<br />

subscription rights by shareholders, but with a public offer, or<br />

for <strong>the</strong> purpose of remunerat<strong>in</strong>g securities that may have been<br />

contributed to <strong>the</strong> Company <strong>in</strong> <strong>the</strong> framework of a public offer<br />

with an exchange component (12th resolution).<br />

The maximum value of shares that may be issued directly or on<br />

presentation of debt <strong>in</strong>struments is €25 million.<br />

The maximum value of securities that may be issued <strong>in</strong> relation<br />

to debt <strong>in</strong>struments is €100 million.<br />

The amount of consideration owed or which may be owed<br />

subsequently to <strong>the</strong> Company for each share issued or to be<br />

issued, with<strong>in</strong> <strong>the</strong> framework of this delegation, will be at least<br />

equal to <strong>the</strong> weighted average of <strong>the</strong> open<strong>in</strong>g price over <strong>the</strong><br />

three trad<strong>in</strong>g days preced<strong>in</strong>g <strong>the</strong> date on which <strong>the</strong> issue price<br />

is set, less any tax relief provided by current legislation and<br />

regulations. This average will be corrected, where necessary, if<br />

<strong>the</strong>re are different due dates. The issue price of equity securities<br />

giv<strong>in</strong>g rights to shares <strong>in</strong> <strong>the</strong> Company would be such that <strong>the</strong><br />

sum received immediately by <strong>the</strong> Company, and, if applicable,<br />

any future proceeds likely to be received by it for each share<br />

issued as a result of <strong>the</strong> issue of <strong>the</strong> o<strong>the</strong>r securities, would be<br />

no less than <strong>the</strong> said issue price (this only applies <strong>in</strong> <strong>the</strong> context<br />

of a public offer with an exchange component).<br />

INFORMATION ABOUT <strong>ANF</strong><br />

Reports and <strong>in</strong><strong>format</strong>ion for <strong>the</strong> Shareholders’ Meet<strong>in</strong>g<br />

�<br />

Contents<br />

On <strong>the</strong> basis of this <strong>in</strong><strong>format</strong>ion, <strong>the</strong> Executive Board will set<br />

<strong>the</strong> issue price of <strong>the</strong> shares issued <strong>in</strong> <strong>the</strong> best <strong>in</strong>terest of <strong>the</strong><br />

Company and its shareholders, tak<strong>in</strong>g <strong>in</strong>to account all relevant<br />

issues.<br />

If necessary, shares issued will be placed accord<strong>in</strong>g to relevant<br />

market practices on <strong>the</strong> issue date.<br />

These last two authorisations give <strong>the</strong> Executive Board some<br />

fl exibility, if required or if <strong>the</strong> opportunity arises, to carry out<br />

immediate or deferred capital <strong>in</strong>creases (through <strong>the</strong> issue of<br />

any type of security permitted <strong>in</strong> law, such as shares, bonds,<br />

convertible bonds, warrants, etc.) without hav<strong>in</strong>g to call a<br />

Shareholders’ Meet<strong>in</strong>g,<br />

• <strong>the</strong> authorisation to <strong>in</strong>crease <strong>the</strong> share capital, with<strong>in</strong> <strong>the</strong><br />

context of an offer pursuant to Article L. 411-2 II of <strong>the</strong> French<br />

Monetary and F<strong>in</strong>ancial Code (“private placement”) and up to<br />

a limit of 20% of <strong>the</strong> Company’s capital on <strong>the</strong> date of <strong>the</strong><br />

transaction, <strong>in</strong> each 12-month period, without pre-emptive<br />

subscription rights, through <strong>the</strong> issue of ord<strong>in</strong>ary shares and/<br />

or securities giv<strong>in</strong>g immediate and/or future rights to a portion<br />

of <strong>the</strong> Company’s capital (13th resolution).<br />

The maximum value of securities that may be issued <strong>in</strong> relation<br />

to debt <strong>in</strong>struments is €100 million.<br />

The amount of consideration owed or which may be owed<br />

subsequently to <strong>the</strong> Company for each share issued or to be<br />

issued, with<strong>in</strong> <strong>the</strong> framework of this delegation, will be at least<br />

equal to <strong>the</strong> weighted average of <strong>the</strong> open<strong>in</strong>g price over <strong>the</strong><br />

three trad<strong>in</strong>g days preced<strong>in</strong>g <strong>the</strong> date on which <strong>the</strong> issue price<br />

is set, less any tax relief provided by current legislation and<br />

regulations. This average will be corrected, where necessary, if<br />

<strong>the</strong>re are different due dates. The issue price of equity securities<br />

giv<strong>in</strong>g rights to shares <strong>in</strong> <strong>the</strong> Company would be such that <strong>the</strong><br />

sum received immediately by <strong>the</strong> Company and, if applicable,<br />

any future proceeds likely to be received by it for each share<br />

issued as a result of <strong>the</strong> issue of <strong>the</strong> o<strong>the</strong>r securities, would be<br />

no less than <strong>the</strong> said issue price.<br />

On <strong>the</strong> basis of this <strong>in</strong><strong>format</strong>ion, <strong>the</strong> Executive Board will set<br />

<strong>the</strong> issue price of <strong>the</strong> shares issued <strong>in</strong> <strong>the</strong> best <strong>in</strong>terest of <strong>the</strong><br />

Company and its shareholders, tak<strong>in</strong>g <strong>in</strong>to account all relevant<br />

issues.<br />

If necessary, shares issued will be placed accord<strong>in</strong>g to relevant<br />

market practices on <strong>the</strong> issue date.<br />

This authorisation gives <strong>the</strong> Executive Board <strong>the</strong> option, if<br />

appropriate, to carry out a private placement to generate,<br />

quickly and fl exibly, <strong>the</strong> funds necessary to fi nance <strong>the</strong><br />

Company’s growth,<br />

• <strong>the</strong> authorisation, <strong>in</strong> <strong>the</strong> case of a capital <strong>in</strong>crease, to set <strong>the</strong><br />

price of shares or securities giv<strong>in</strong>g immediate and/or future<br />

rights to shares, without pre-emptive subscription rights, up to<br />

a limit of 10% of <strong>the</strong> share capital (14th resolution),<br />

• <strong>the</strong> authorisation to <strong>in</strong>crease <strong>the</strong> number of shares, <strong>in</strong>struments<br />

or securities to be issued <strong>in</strong> <strong>the</strong> case of an <strong>in</strong>crease <strong>in</strong> <strong>the</strong><br />

<strong>ANF</strong> • <strong>2009</strong> ANNUAL REPORT<br />

99<br />

OTHER GENERAL GENERAL INFORMATION PRO FORMA FINANCIAL INFORMATION ANNUAL ANNUAL FINANCIAL STATEMENTS CONSOLIDATED FINANCIAL FINANCIAL STATEMENTS INFORMATION ABOUT <strong>ANF</strong> DESCRIPTION OF THE BUSINESS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!